Adaptive Biotechnologies Corp vs PayPal Holdings, Inc. — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while PayPal Holdings, Inc. trades at $57.97 (market cap $50.47B). The key difference: PayPal Holdings, Inc. is far larger — about 12.5× Adaptive Biotechnologies Corp's market cap, and PayPal Holdings, Inc. pays a 0.95% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | PYPL | |
|---|---|---|
Market Cap | $4.04B | $50.47B |
Sector | Health | Financials |
52-Week High | $25.45 | $76.13 |
52-Week Low | $12.30 | $39.08 |
Enterprise Value | $4.10B | $52.62B |
Dividend Yield | — | 0.95% |
Trailing returns across standard periods
Latest headlines on both assets
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →